Identification of spectrum of persistent post-COVID-19 symptoms and their duration in Central India: A pilot study.

Autor: Sudha TYS; Department of Pharmacology, All India Institute of Medical Sciences, Deoghar, Jharkhand, India., Sasanka KSBSK; ENT, All India Institute of Medical Sciences, Deoghar, Jharkhand, India., Thangaraju P; Departments of Pharmacology, All India Institute of Medical Sciences, Raipur, Chhattisgarh, India., Kuotsu R; ENT All India Institute of Medical Sciences, Raipur, Chhattisgarh, India., William AG; Pharmacology, Government Medical College, Kanker, Chhttisghar, India.
Jazyk: angličtina
Zdroj: Journal of family medicine and primary care [J Family Med Prim Care] 2022 Dec; Vol. 11 (12), pp. 7850-7856. Date of Electronic Publication: 2023 Jan 17.
DOI: 10.4103/jfmpc.jfmpc_801_22
Abstrakt: Objectives: To uncover numerous post-COVID symptoms in individuals after SARS-CoV-2 infection and to raise concerns about the consequences for health care planning.
Methodology: Patients declared negative with RTPCR and discharged from the hospital were followed up for three months.
Results: The majority of patients who suffered from weakness since discharge are 63 (25.40%), body aches 40 (16.12%), loss of taste 26 (10.48%), and loss of smell 18 (7.25%). The total of reinfected patients in the 4 th week was 9 (3.62%), in the 6 th week 10 (4.03%), in the 8 th week 7 (2.82%), and in the 12 th week 11 (4.43%). A total of 54.7% of individuals still have the persistence of symptoms at the end of the 12 th week.
Conclusions: A significant number of participants developed long-term health issues as a result of post-COVID-19 syndrome. Our findings highlight the importance of initial preventive measures and patient-centered benefit programs in reducing post-COVID-19 complications.
Competing Interests: There are no conflicts of interest.
(Copyright: © 2023 Journal of Family Medicine and Primary Care.)
Databáze: MEDLINE
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje